Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Robert M. Guthrie. (2013) Use of Home-Based Subcutaneous Immunoglobulin Therapy in Elderly Patients with Primary Immunodeficiency Diseases. Postgraduate Medicine 125:1, pages 169-171.
Read now
Read now
Isaac Melamed, Alessandro Testori & Zvi Spirer. (2012) Subcutaneous Immunoglobulins: Product Characteristics and Their Role in Primary Immunodeficiency Disease. International Reviews of Immunology 31:6, pages 451-461.
Read now
Read now
Articles from other publishers (18)
Kevin Rosenbach, Michelle Park, Marie Sanchirico, Oliseyenum Nwose & Kenneth Paris. (2023) Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment. Journal of Clinical Immunology 43:5, pages 912-920.
Crossref
Crossref
Kristin Epland, Daniel Suez & Kenneth Paris. (2022) A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases. Allergy, Asthma & Clinical Immunology 18:1.
Crossref
Crossref
Ulrich Baumann, Maria Fasshauer, Christine Pausch, Helmut Wittkowski, Corinna Hermann, David Pittrow & Michael Borte. (2022) Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases. Immunotherapy 14:2, pages 135-143.
Crossref
Crossref
Irina Dawson & Mark Ballow. 2021. Primary and Secondary Immunodeficiency. Primary and Secondary Immunodeficiency
381
395
.
Pieter van Paassen, David Pittrow, Clemens Scheidegger, Jens Klotsche & Pauline M Ellerbroek. (2020) Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients. Immunotherapy 12:2, pages 131-139.
Crossref
Crossref
Niraj C. Patel. (2018) Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease. Pediatric Allergy and Immunology 29:6, pages 583-588.
Crossref
Crossref
Ekaterini Simões Goudouris, Almerinda Maria do Rego Silva, Aluce Loureiro Ouricuri, Anete Sevciovic Grumach, Antonio Condino-Neto, Beatriz Tavares Costa-Carvalho, Carolina Cardoso de Mello Prando, Cristina Maria Kokron, Dewton de Moraes Vasconcelos, Fabíola Scancetti Tavares, Gesmar Rodrigues Silva Segundo, Irma Cecília Douglas Paes Barreto, Mayra de Barros Dorna, Myrthes Anna Maragna Toledo Barros & Wilma Carvalho Neves Forte. (2017) II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. Einstein (São Paulo) 15:1, pages 1-16.
Crossref
Crossref
Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn, Morna Dorsey, Yehia El-Gamal, Terry O. Harville, Elham Hossny, Bruce Mazer, Robert Nelson, Elizabeth Secord, Stanley C. Jordan, E. Richard Stiehm, Ashley A. Vo & Mark Ballow. (2017) Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology 139:3, pages S1-S46.
Crossref
Crossref
Eric M. Tichy & Leslie Vaughan. (2016) Selecting a polyclonal immune globulin treatment for a patient with primary immune deficiency disease: Role of the clinical pharmacist. American Journal of Health-System Pharmacy 73:8, pages 533-546.
Crossref
Crossref
Jordan S. Orange, Filiz O. Seeborg, Marcia Boyle, Christopher Scalchunes & Vivian Hernandez-Trujillo. (2016) Family Physician Perspectives on Primary Immunodeficiency Diseases. Frontiers in Medicine 3.
Crossref
Crossref
S Jolles, J S Orange, A Gardulf, M R Stein, R Shapiro, M Borte & M Berger. (2015) Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clinical and Experimental Immunology 179:2, pages 146-160.
Crossref
Crossref
Alan P Koterba & Mark R Stein. (2014) Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy. Allergy, Asthma & Clinical Immunology 10:1.
Crossref
Crossref
Melvin Berger. (2014) Subcutaneous IgG in neurologic diseases. Immunotherapy 6:1, pages 71-83.
Crossref
Crossref
Nisha Verma, Anthony Thaventhiran, Benjamin Gathmann, James Thaventhiran & Bodo Grimbacher. (2013) Therapeutic Management of Primary Immunodeficiency in Older Patients. Drugs & Aging 30:7, pages 503-512.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Allergy & Clinical Immunology 12:6, pages 670-675.
Crossref
Crossref
Mark Ballow. (2012) Dosing and Therapy Utilization: A Discussion of Updates on PI Treatment Guidelines. Journal of Clinical Immunology 32:S2, pages 415-420.
Crossref
Crossref
Ralph Shapiro. (2012) Subcutaneous Immunoglobulin. Immunology and Allergy Clinics of North America.
Crossref
Crossref
Melvin Berger. (2011) Choices in IgG replacement therapy for primary immune deficiency diseases. Current Opinion in Allergy & Clinical Immunology 11:6, pages 532-538.
Crossref
Crossref